This work presents data on the study of the possibility of using the natural polysaccharide chitosan and a synthetic polymer of polyvinyl alcohol as a matrix for creating a polymer form in the form of a film with prolonged drug release. Eye films based on chitosan, as well as on the basis of chitosan and polyvinyl alcohol, have been developed by obtaining a composite injection. The immobilization of antibiotics in polyvinyl alcohol films leads to a pro nounced prolongation of the antibiotic action, at the same time, it significantly increases the penetration of the drug into the tissues and eye fluids, providing the necessary therapeutic concentration for 1 day, which certainly becomes a significant advantage of antibiotic administration methods. To study the yield of drugs from polymer dosage forms, the method of UV spectroscopy was used. The influence of the concentration of drugs on the dynamics of their release from polymer films in «in vitro» conditions was studied. It was found that their chitosan / PVA film has a longer release of the drug, which is indicative of a prolongation effect. The results which were obtained indicate the possibility of using a dosage form based on biocompatible high molecular weight compounds to create therapeutic systems with a diffusion mechanism of drug release.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.